Marseille, 4 May 2026 – The first time Francesca Barone sat in a Boston café and overheard people around her discussing flow cytometry and the latest scientific discoveries, she felt she was exactly where she was meant to be. “I am a nerd at heart, so if I can do research and learn new things, […]
NANOLOGIC x Cell-Scale: Engineering Precision CAR-T for Solid Tumors
Marseille, April 14 2026 –Interview with Rémi Lasserre, Inserm researcher at the Cancer Research Centre of Marseille (CRCM). At the Cancer Research Centre of Marseille (CRCM), Inserm researcher Rémi Lasserre focuses on lymphocytes and how they can be engineered into powerful therapeutic tools. He is currently collaborating with the Cell-Scale platform, within Marseille Immunology Biocluster […]
The Beacon Installed on the B-SCREEN Platform at IHU Méditerranée Infection
Accelerating innovation in infectious diseases requires strong links between patient samples, advanced research and therapeutic development. Marseille, March 9, 2026 –Following more than six months of collaborative work, Beacon™ technology has now been installed on the B-SCREEN platform at IHU Méditerranée Infection in Marseille. This marks an important step in establishing a long-term collaboration between […]
CRISTO 2026: a new scientific meeting dedicated to translational immunology
CRISTO 2026 On April 10, 2026, the first edition of CRISTO (Clinical Research Interfaces with Translational Objectives) will take place at the Palais du Pharo in Marseille. Led by: the Clinical Investigation Centre (CIC U1409) and jointly organized by: l’Assistance Publique – Hôpitaux de Marseille (AP-HM), Marseille Immunology Biocluster, Aix-Marseille Université, and Inserm CRISTO aims to […]
Interview with Jacques Nunès – From antibodies to CARs: how CELL-SCALE accelerates innovation in cell therapy
Marseille, 23 February 2026 – Cell therapy is one of the most rapidly evolving fields in immunotherapy. However, translating an academic discovery into a therapeutic approach remains a challenge for many laboratories. The CELL-SCALE platform, developed within Marseille Immunology Biocluster (MIB), aims to accelerate this transition. Could you explain what CELL-SCALE and CARATS are? CELL-SCALE […]
Expert insight – Daniel Olive : Why French Immunology Must Communicate to Lead
Why French Immunology Must Communicate to Lead ? Marseille, 16 February 2026 – France has long been home to outstanding immunology research. Our scientists contribute every day to advances in cancer, infectious diseases, transplantation, autoimmune disorders, and vaccine development. And yet, despite this central role, French immunology research still struggles to be recognized on the […]
Cell-Scale: A new strategic platform dedicated to Cell Therapies within MIB
Marseille, January 8, 2025 – Marseille Immunology Biocluster marks a new milestone in the development of translational immunology with the operational launch of Cell-Scale, a state-of-the-art technological platform dedicated to the engineering and development of innovative cell therapies. Designed to address the scientific and technological challenges of next-generation immunotherapies, Cell-Scale is now fully operational and […]
Meet Chafik Hamdad, Life Sciences Research Engineer for B-SCREEN
Within the B-SCREEN platform, Chafik Hamdad leverages his expertise in life sciences, biotechnology and biological data analysis to contribute to the identification of B cells and therapeutic antibodies from patient samples. Marseille, June 25, 2026 – Chafik Hamdad has spent several years in biotechnology R&D, developing expertise in next-generation sequencing, cellular and molecular biology, immuno-oncology and […]
An Innovative Cell Therapy for Triple-Negative Breast Cancer
During this National Breast Cancer Awareness Month, dedicated to raising awareness of breast cancer, a promising breakthrough has emerged at the CRCM – Marseille Cancer Research Center. Marseille, November 23, 2025 – Under the leadership of Prof. Daniel Olive and Dr. Marc Lopez, a team of researchers has developed a new generation of CAR-T cells […]
ImmunoSkills: €3 Million to train the immunotherapy experts of tomorrow
The ‘Campus des Métiers et des Qualifications d’Excellence’ announced on Tuesday, September 29, 2025, that the French government will provide €3 million in funding to train the next generation of immunotherapy specialists. Marseille, September 23, 2025 – The ImmunoSkills project, developed in partnership with the Marseille Immunology Biocluster (MIB), has been selected as a laureate […]